ACKNOWLEDGEMENTS;
Haematology Lab team, Agha Khan university Hospital, Karachi, Pakistan for secondary review & Paediatric Oncology Eastern and Mediterranean Group (POEM) for MDT discussion.
REFERENCES ;
  1. Hauck G, Jonigk D, Kreipe H, Hussein K,. Simultaneous and sequential concurrent myeloproliferative and lymphoproliferative neoplasms. Acta Haematol 2013; 129:187–96.
  2. Cancer in children (ages 0-14 and ages 0-19). Horner MJ, Ries LAG, Krapcho M, eds. SEER Cancer Statistics Review, 1975-2006. Bethesda, Md: National Cancer Institute; 2008.
  3. Ries LAG, Smith M, Gurney JG, et al, eds. Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995. In: National Cancer Institute, vol. 99. Bethesda, MD: SEER Program; 1999:46-49.
  4. Vardiman, J.W.; Thiele, J.; Arber, D.A.; Brunning, R.D.; Borowitz, M.J.; Porwit, A.; Harris, N.L.; Le Beau, M.M.; Hellström-Lindberg, E.; Tefferi, A.; et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: Rationale and important changes. Blood 2009, 114, 937–51.
  5. Gotlib, J.; Maxson, J.E.; George, T.I.; Tyner, J.W. The new genetics of chronic neutrophilic leukemia and atypical CML: Implications for diagnosis and treatment. Blood 2013;122:1707–11.
  6. Arber, D.A.; Orazi, A.; Hasserjian, R.; Thiele, J.; Borowitz, M.J.; Le Beau, M.M.; Bloomfield, C.D.; Cazzola, M.; Vardiman, J.W. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 2016;127:2391–405.
  7. Miranda MB, Lauseker M, et al. Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV. Leukemia2016;30:1255-62.
  8. Fu X, Shang Y, Zhang L, et al. Analyses and treatment of simultaneous bi-lineage malignancies of myeloid leukemia and lymphoma: Two case reports and a literature review. Oncol Lett. 2018;16(5):6624-6632. doi:10.3892/ol.2018.9447.
  9. Ichinohasama R, Miura I, Takahashi N, Sugawara T, Tamate E, Endoh K, Endoh F, Naganuma H, DeCoteau JF, Griffin JD, Kadin ME, Ooya K. Ph-negative non-Hodgkin’s lymphoma occurring in chronic phase of Ph-positive chronic myelogenous leukemia is defined as a genetically different neoplasm from extramedullary localized blast crisis: report of two cases and review of the literature. Leukemia. 2000;14:169-82.
  10. Melikian A.L, Kolosheĭnova T.I, Goriacheva S.R., et al. Synchronous and metachronous myeloid and lymphoid tumors. Terapevticheskii arkhiv. 2014; 86.:37-44.
  11. Teachey DT, O’Connor D. How I treat newly diagnosed T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma in children. Blood2020; 135:159-66.
  12. Onida, F.; de Wreede, L.C.; van Biezen, A.; Eikema, D.-J.; Byrne, J.L.; Iori, A.P.; Schots, R.; Jungova, A.; Schetelig, J.; Finke, J.; et al. Allogeneic stem cell transplantation in patients with atypical chronic myeloid leukaemia: A retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation. Br. J. Haematol. 2017, 177, 759–765.
  13. Jiang, H.; Wu, Z.; Ren, L.; Tao, D.; Tong, H. Decitabine for the treatment of atypical chronic myeloid leukemia: A report of two cases. Oncol. Lett. 2016, 11, 689–692
  14. Freedman, J.L.; Desai, A.V.; Bailey, L.C.; Aplenc, R.; Burnworth, B.; Zehentner, B.K.; Teachey, D.T.; Wertheim, G. Atypical Chronic Myeloid Leukemia in Two Pediatric Patients. Pediatr. Blood Cancer 2016, 63, 156–159.